Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

How I’d invest £500 in UK shares today

This Fool explains how he’d put a lump sum of £500 to work in a basket of UK shares to capitalise on the economic recovery.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If I had to invest a lump sum of £500 in UK shares today, I’d target two different types of stock.

On the one hand, I’d pick a high-quality business, a company with high profit margins that should continue to prosper, no matter what the future holds for the UK economy.

Meanwhile, on the other hand, I’d buy a recovery stock. This could be a company with a bit of an uncertain future, which can generate high returns if the UK economy grows rapidly over the next few years. 

I’d also add a third business to my basket of UK shares. This company would have a mix of the two qualities outlined above. I think this combination of quality and recovery stocks could be the best way to invest £500. 

UK shares to buy

The high-quality enterprise I’d buy for my portfolio of UK shares is AstraZeneca. I think this company has all the hallmarks of a business that can grow year after year. Healthcare is an incredibly stable industry because there’ll always be a growing need for healthcare and related services.

As one of the largest pharmaceutical companies in the world, Astra has a considerable competitive advantage in its existing product portfolio and research and development pipeline.

Of course, there’ll always be a risk that the company’s research efforts don’t yield results. The pharmaceutical sector is also fiercely competitive. These are the key obstacles facing the enterprise. 

The recovery stock I’d buy for my £500 portfolio is Landsec. This landlord has suffered from falling property prices and low levels of rent collection over the past year. The pandemic may also have lasting effects on the firm’s office properties if there’s a significant shift towards working from home.

That’s the most considerable risk the business faces today. Still, I’d buy the stock as a recovery play because its portfolio of properties can always be re-purposed. In addition, it owns some valuable real estate in London, which might have suffered a drop in value over the past 12 months but is unlikely to remain cheap for long, in my opinion. 

The best of both worlds

The final share I’d buy for my portfolio of UK shares is Lloyds Bank. I think this stock offers the best of both worlds. As the economy recovers, I believe the firm’s earnings should improve, thanks to higher lending levels. At the same time, as one of the UK’s largest banks, there’ll always be a demand for the lender’s services.

I think these qualities suggest the stock is both a recovery and defensive investment. The group’s main challenge at the moment is low interest rates. Low rates are compressing profit margins, and if they drop further, Lloyds’ profits will drop further as well.

Rupert Hargreaves owns shares in Landsec. The Motley Fool UK has recommended Landsec and Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

How much do you need in an ISA to target a £1,700 monthly passive income?

Charlie Carman explains how investors can aim to generate effortless passive income by turning their Stocks and Shares ISA into…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

3 Warren Buffett investing ideas I plan to use in 2026

After decades in the top job at Berkshire Hathaway, Warren Buffett is preparing to step aside. But this writer will…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

Looking to earn a second income next year (and every year)? Here’s one approach.

Christopher Ruane explains how some prudent investment decisions now could potentially help set someone up with a second income in…

Read more »

Senior woman potting plant in garden at home
Investing Articles

Could a 10%+ yielding dividend share like this make sense for a retirement portfolio?

With a double-digit percentage yield, could this FTSE 250 share be worth considering for a retirement portfolio? Our writer weighs…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

Forget Rigetti and IonQ: here’s a quantum computing growth stock that actually looks cheap

Edward Sheldon has found a growth stock in the quantum computing space with lots of potential and a really attractive…

Read more »

UK money in a Jar on a background
Investing Articles

Here’s a £3 a day passive income plan for 2026!

Looking for a simple and cheap plan to try and earn passive income in 2026 and beyond? Christopher Ruane shares…

Read more »

Blue NIO sports car in Oslo showroom
Investing Articles

NIO stock’s down 35% since October. Time to buy?

NIO stock has had a roller coaster year so far! Christopher Ruane looks at some of the highs and lows…

Read more »

Investing Articles

By December 2026, £1,000 invested in BAE Systems shares could be worth…

Where will BAE Systems shares be in a year's time? Here is our Foolish author's review of the latest analyst…

Read more »